US stock · figures in US dollars · scored on full-year results
HCA Healthcare HCA Healthcare, Inc. Common Stock
HCA Healthcare scores 54/100 on fundamentals: in the top 49% of 503 scored S&P 500 stocks. Its strongest area is Risk (70/100); its weakest is Price Fairness (33/100). It carries 1 warning flag: Limited Data.
- Carries a Limited Data flag
This stock is fairly balanced overall: price fairness is its weakest area.
Nearby peers
Ranks #29 of 60 in Healthcare by score
One-Minute Summary
Why HCA Healthcare scores 54
This stock is fairly balanced overall: price fairness is its weakest area.
Business Strength
50Why 50?
No data: Quarterly Momentum
Show 3 charts
Net Profit & Equity, with ROE
Revenue & Net Profit, with Net Margin
Sales grew about 21.1% over 4 years: customers keep spending more with this company.
Profit climbed about 29.3% over 4 years: the business keeps more money as it grows.
Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)
Sales grew about 8.7% over the last 5 quarters: customers keep spending more with this company.
Profit has moved sideways over the last 5 quarters.
Financial Safety
67Why 67?
Show 2 charts
Debt vs Equity, with D/E ratio
Borrowings grew about 25.2% over 4 years: watch this; rising debt adds pressure in bad times.
Short-term assets vs bills, with Current Ratio
Cash & Dividends
50Why 50?
Show 3 charts
Operating vs Free Cash Flow
The business generates real cash, and more of it each year: a very healthy sign.
Cash vs Total Debt
Dividends per Share, with Yield
Dividends per share have been maintained or raised: management shares the rewards with you.
Price FairnessLowest pillar
33Why 33?
Show chart
Share Price: Weekly Closes (not part of the score)
The share price has been roughly flat over the past year.
Risk
70Why 70?
No data: Quarterly Consistency
Show chart
Revenue vs Inventory, with Inventory % of Revenue
Sector peers
HCA Healthcare (HCA) scores 54/100 (Okay) on Score Your Stock's educational fundamentals model: in the top 49% of 503 scored S&P 500 stocks.
Its strongest pillar is Risk (70/100); its weakest is Price Fairness (33/100).
HCA Healthcare ranks #29 of 60 scored Healthcare stocks on Score Your Stock.
Yes. HCA Healthcare (HCA) has a dividend yield of 0.7%, from dividends with an ex-date in the last 12 months. It pays out 10% of its profit as dividends. Its Cash & Dividends pillar scores 50/100.
From Malaysia, open an account with a broker that offers US shares (many local and app-based brokers do), convert ringgit to US dollars, then buy HCA. US shares trade one share at a time, not in lots of 100. Check the currency conversion fee and US dividend tax (usually 30% withheld for Malaysians) before you buy.
The overall score pools every measure across 5 weighted pillars: Business Strength, Financial Safety, Cash & Dividends, Price Fairness, and Risk. It uses the same rules as our Bursa scores. For banks, Financial Safety checks nonaccrual (impaired) loans, loan loss coverage and the CET1 capital ratio, from the FDIC call report of the group's main bank. Full methodology and the default weights: https://scoreyourstock.com/how. This is an educational tool, not investment advice.
HCA Healthcare (HCA) is a Healthcare company (Medical Care Facilities). On Score Your Stock's fundamentals check, it scores 54/100, rated Okay. Its biggest strength is Risk (70/100); its main watch-out is Price Fairness (33/100). Shares currently cost about 15 years of its current profit to buy (P/E 14.7×). It also pays back about 0.7% of the share price as dividends each year. Full breakdown and daily-updated score: https://scoreyourstock.com/stocks/us/hca-hca-healthcare
Full Financial History
Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.
| Financial Year | Revenue | Net Profit | Operating Cash Flow | Free Cash Flow | CapEx | Cash | Total Debt | Short-Term Debt | Equity | Current Assets | Current Liabilities | Total Assets | Total Liabilities | Inventory | Dividends | Return on Equity (ROE) | Net Profit Margin | Debt-to-Equity | Current Ratio | Interest Coverage | Dividend Payout Ratio | Div yield | P/E Ratio | P/B Ratio | PEG Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | US$ 78.7b | US$ 6.8b | US$ 11.2b | US$ 6.0b | US$ -5.2b | US$ 908.0m | US$ 52.4b | US$ 8.1b | US$ -8.1b | US$ 16.2b | US$ 19.8b | US$ 63.5b | US$ 68.1b | US$ 1.7b | - | -84% | 9% | -6.5× | 0.8× | 5.2× | 10% | - | - | - | - |
| 2025 | US$ 75.6b | US$ 6.8b | US$ 12.6b | US$ 7.7b | US$ -4.9b | US$ 1.0b | US$ 48.7b | US$ 4.9b | US$ -6.0b | US$ 15.8b | US$ 16.4b | US$ 60.7b | US$ 63.5b | US$ 1.7b | US$ 288.0m | -113% | 9% | -8.1× | 1.0× | 5.4× | 10% | 1% | 15.5× | -17.4× | 2.5 |
| 2024 | US$ 70.6b | US$ 5.8b | US$ 10.5b | US$ 5.6b | US$ -4.9b | US$ 1.9b | US$ 45.2b | US$ 4.7b | US$ -2.5b | US$ 16.4b | US$ 15.2b | US$ 59.5b | US$ 59.0b | US$ 1.7b | US$ 264.0m | -230% | 8% | -18.1× | 1.1× | 5.1× | 12% | 1% | 12.7× | -29.3× | - |
| 2023 | US$ 65.0b | US$ 5.2b | US$ 9.4b | US$ 4.7b | US$ -4.7b | US$ 935.0m | US$ 41.9b | US$ 2.4b | US$ -1.8b | US$ 14.9b | US$ 12.7b | US$ 56.2b | US$ 55.2b | US$ 2.0b | US$ 240.0m | -295% | 8% | -23.6× | 1.2× | 5.0× | 13% | 1% | 13.4× | -39.7× | 1.1 |